Navigation Links
uBiome to Host Second Annual Microbiome Conference at JP Morgan 37th Annual Healthcare Conference
Date:12/27/2018

uBiome, the leader in microbial genomics, announces the second annual Microbiome Conference at JPM as part of the JP Morgan 37th Annual Healthcare Conference in San Francisco, which brings together industry leaders, emerging fast-growth companies, innovative scientists and physicians, and members of the investment community.

Since its origin in 1983, the JP Morgan Healthcare Conference has grown to welcome thousands of investors and companies from new startups to those with more than $300 billion in market capital, encompassing the entire global healthcare landscape including pharmaceutical firms, healthcare service providers, profit and not-for-profits, and medical device companies.

The microbiome has a profound effect on human health, including synthesizing vitamins, metabolizing nutrients, impacting immune response, and interacting with hormones to affect human health. Given that recent research suggests microbes influence body systems and various health conditions, understanding and further manipulating these interactions may allow for better management and treatment of conditions.

“uBiome is excited to be a part of JPM and we look forward to discussing the implications of the microbiome for healthcare with leaders in the industry,” Dr. Jessica Richman, PhD, co-founder and CEO of uBiome said, “The microbiome is essential for human health, and JPM is the ideal place to continue this dialogue.”

To learn more about uBiome’s efforts, please visit https://ubiome.com/about-us/.

About uBiome
Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets. uBiome has filed for over 250 patents on its technology, which includes sample preparation, computational analysis, molecular techniques, as well as diagnostic and therapeutic applications.

uBiome’s commercial products include SmartGut™, the world’s first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn’s Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women’s health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.

uBiome’s platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.

Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.

Read the full story at https://www.prweb.com/releases/ubiome_to_host_second_annual_microbiome_conference_at_jp_morgan_37th_annual_healthcare_conference/prweb16001326.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. uBiome Receives Patent for Microbiome-Derived Diagnostics and Therapeutics for Immune-Microbial Dysfunction
2. uBiome Appoints Dr. Amir Zarrinpar, MD, PhD, Assistant Professor in the Division of Gastroenterology at UC San Diego, to its Medical Advisory Board
3. uBiome Appoints Dr. Brandon Wuerth, MD, Founder of IBDwatch, to its Medical Advisory Board
4. uBiome Appoints Dr. Emeran Mayer, MD, World-Renowned Gastroenterologist and Neuroscientist, to its Medical Advisory Board
5. uBiome Appoints Dr. Jill Carnahan, MD, Functional Medicine Expert, to its Medical Advisory Board
6. uBiome Appoints Dr. Catherine Lozupone, PhD, Respected Microbiologist, to its Scientific Advisory Board
7. uBiome Appoints Leading Biochemist Dr. Joseph DeRisi to Board of Directors
8. uBiome Appoints Dr. Donnica Moore, MD, Women's Health Expert and Advocate, to its Medical Advisory Board
9. uBiome Appoints Dr. Jonathan Braun, MD, PhD, Prominent UCLA Physician-Researcher, to its Scientific Advisory Board
10. uBiome Appoints Kathie Swift, MS, RDN, FAND, Co-founder of the Integrative and Functional Nutrition Academy, to its Scientific Advisory Board
11. uBiome Appoints Dr. Steven Medwell, MD, Distinguished Colorectal Surgeon, to its Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2018)... CITY, N.Y. (PRWEB) , ... December 19, 2018 , ... ... the most innovative products in healthcare for 2018. , PM360 is featuring the ... most innovative products and services offered to the pharmaceutical and medical device industries. ...
(Date:12/18/2018)... ... 18, 2018 , ... Nativis, Inc. , a clinical ... today announced the publication of an early feasibility study in CNS Oncology suggesting ... The publication of the study, An Early Feasibility Study of the Nativis Voyager® ...
(Date:12/13/2018)... ... 13, 2018 , ... Study Protocol Summary of QC Procedure , 1 – ... assessment performed at the site., 3 - Three photos captured with Apple iPad and ... BOX., 5 - Photos moved to eAdjudication® and submitted to Reviewers., 6 - ...
Breaking Biology News(10 mins):
(Date:1/4/2019)... ... January 02, 2019 , ... CellMax Life ... cells in blood, has been named as a partner in Medigen Biotech’s upcoming ... cell therapies for cancer treatment, will use CellMax Life’s circulating tumor cell platform ...
(Date:12/19/2018)... ... 19, 2018 , ... R3 Stem Cell is now offering ... in Las Vegas. Training includes facial rejuvenation, hair restoration and erectile dysfunction procedures ... aesthetics, having the training from expert, Board Certified providers is critical to instilling ...
(Date:12/18/2018)... ... December 18, 2018 , ... USDM Life Sciences, the leading ... industry, unveiled a completely redesigned website at http://www.usdm.com . The site offers ... their valued clients and business partners. , The website has a revamped ...
(Date:12/13/2018)... ... December 11, 2018 , ... Researchers at ... use to quickly detect Clostridium difficile (C. diff), a dangerous and sometimes fatal ... device that can be used onsite in doctor’s offices and nursing homes, providing ...
Breaking Biology Technology: